$28.39
-0.37-1.29%
Last update: Oct 30, 4:00 PM
Zenas BioPharma Inc (ZBIO) Stock Price, Quote, News & History
ZBIONASDAQ
US stock futures rise, Dow futures up 300 points. Lennar Corp falls after reporting mixed Q2 results. Other stocks declining in pre-market trading.
You can purchase shares of Zenas BioPharma (NASDAQ:ZBIO) through any online brokerage.
Other companies in Zenas BioPharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Zenas BioPharma has a consensus price target of $40.78.
The stock price for Zenas BioPharma (NASDAQ: ZBIO) is $28.39 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Zenas BioPharma.
Zenas BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for Zenas BioPharma.
Zenas BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the...
